会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • VIP AND AN ALPHA-ADRENERGIC BLOCKER FOR USE IN THE DIAGNOSIS OF ERECTILE DYSFUNCTION AND VASCULAR ISCHAEMIA
    • VIP和ALPHA-ADRENERGIC阻塞器用于诊断溃疡性功能障碍和血管异位症
    • WO2014080162A1
    • 2014-05-30
    • PCT/GB2013/000509
    • 2013-11-21
    • MENS HEALTH LTD
    • WYLLIE, Mike
    • A61K38/22A61K45/06A61P9/10
    • A61K38/2278A61K31/417A61K45/06A61K2300/00
    • The present invention provides a method of providing an objective, repeatable measure of the severity of an erectile dysfunction condition comprising: a) the administration in a therapeutically effective amount of a physiological mediator of penile erection, generally a vasoactive intestinal peptide (VIP) and a therapeutically effective amount of an alpha-adrenergic blocker; b) measuring the erectile response; c) grading the severity of the ED condition through the erectile response measurements. There is also provided a method of diagnosing a patient suffering from vascular ischaemia comprising: • identifying an area of the body (typically a limb) exhibiting symptoms of vascular ischaemia; • administering a therapeutically effective amount of a vasoactive intestinal peptide (VIP) and a therapeutically effective amount of an alpha-adrenergic blocker; wherein if the symptoms of vascular ischaemia are alleviated, eliminated or relieved within a predetermined period from administration, the patient is likely to be suffering from vascular ischaemia. The VIP is generally included in a composition having a pH of from around 6 to around 9.
    • 本发明提供了提供勃起功能障碍病症严重程度的客观可重复测量的方法,包括:a)以治疗有效量的阴茎勃起生理介质(通常为血管活性肠肽(VIP))和 治疗有效量的α-肾上腺素能阻滞剂; b)测量勃起反应; c)通过勃起反应测量法评估ED病情的严重程度。 还提供了一种诊断患有血管缺血的患者的方法,包括:•鉴定表现血管缺血症状的身体区域(通常为肢体); •施用治疗有效量的血管活性肠肽(VIP)和治疗有效量的α-肾上腺素能阻滞剂; 其中如果血管局部缺血的症状在给药的预定时间内缓解,消除或缓解,则患者可能患有血管缺血。 VIP通常包括在pH为约6至约9的组合物中。
    • 7. 发明申请
    • SCREENING METHOD AND APPARATUS
    • WO2014057233A3
    • 2014-04-17
    • PCT/GB2013/000420
    • 2013-10-08
    • LANCASTER UNIVERSITY BUSINESS ENTERPRISES LTD
    • FORDE, Brian Gordon
    • A01G9/10G06K9/00G06T7/00
    • According to the present invention there is provided an organism growth array device suitable for automated phenotypic analysis of either plants or microorganisms under aseptic conditions and comprising: a plurality of receptacles, each receptacle having a housing comprising first and second open ends and one or more longitudinal sides extending from the first open end to the second open end, wherein at least one of the longitudinal sides is flat, and wherein a portion of each receptacle is fused to the neighbouring receptacle(s) along at least 10% of its length along the longitudinal axis of the receptacle; growth medium housed within the housing extending from a first surface of the growth medium, disposed longitudinally towards the first open end of the receptacle to a second surface of the growth medium disposed towards the second open end of the receptacle, wherein generally, in use, the first surface of the growth medium is disposed above the second surface of the growth medium; wherein the open ends of each receptacle are individually accessible, preferably for the addition of different compositions; and wherein the growth medium of each receptacle is visible, and imagable across the lateral axis of the receptacle and along the longitudinal axis of the receptacle from the first surface to the second surface, and in use the growth of the organism within or into the growth medium is visible and imagable across the lateral axis of the receptacle and along the longitudinal length of the growth medium. There is also provided a method of imaging and/or analysing the development of one or more organisms.
    • 8. 发明申请
    • APPARATUS
    • 仪器
    • WO2013186513A2
    • 2013-12-19
    • PCT/GB2013/000257
    • 2013-06-11
    • SOFTCELL MEDICALS LIMITED
    • MCINTOSH, Kirsty
    • A61B5/145
    • A61B5/14539A61B5/14503A61B5/1473A61B5/1495A61B5/4519A61B5/4848A61B5/7275A61B5/7282A61B5/742A61B5/746A61B2560/0228A61B2560/0276A61B2560/028A61B2562/242
    • The present invention relates to a pH sensor adapted to be inserted into all soft tissues, such as muscle, fat or other organs e.g. heart, lung, kidney, liver, pancreas, renal gland etc., comprising one or more of: a) means to provide sensor calibration performance information; b) a sensor dislodgement alert, providing an indication to the user if the pH reading falls outside a predetermined range; c) an alert to indicate that the sensor has exceeded its usage period; and d) an alert to indicate that the sensor had exceeded its shelf life. There is also provided a method of assessing the efficacy of a treatment regime comprising the steps of determining any change in the pH of the soft tissue during treatment, where any change in the pH towards the preferred range for the tissue type is indicative of an effective treatment regime and any change in the pH away from the preferred range for the tissue type is indicative of a worsening in the condition of the tissue, and thus an ineffective treatment regime.
    • 本发明涉及适于插入所有软组织如肌肉,脂肪或其他器官的pH传感器, 心脏,肺,肾,肝,胰腺,肾腺等,包括以下一个或多个:a)提供传感器校准性能信息的手段; b)传感器移动警报,如果pH读数落在预定范围之外,则向用户提供指示; c)警报以指示传感器已超出其使用期限; 和d)警报以指示传感器已超过其保质期。 还提供了一种评估治疗方案的功效的方法,其包括以下步骤:在治疗期间确定软组织的pH值的任何变化,其中对于组织类型,pH朝向优选范围的任何变化指示有效 治疗方案和离开组织类型的优选范围的pH的任何变化表明组织状况恶化,从而导致无效的治疗方案。
    • 9. 发明申请
    • CROSS SITE, CROSS DOMAIN SESSION SHARING WITHOUT DATABASE REPLICATION
    • 交叉站点,跨域会话共享,无数据库复制
    • WO2010023556A2
    • 2010-03-04
    • PCT/IB2009/006954
    • 2009-08-28
    • AVG TECHNOLOGIES CZ, S.R.O.SEDLACEK, Vladimir
    • SEDLACEK, Vladimir
    • H04L67/1008H04L67/1002H04L67/101H04L67/1014H04L67/1017H04L67/1027H04L67/1029H04L67/14
    • A method of providing access to data via a public communications network includes the receiving a first data session request having a storage group mark, the storage group mark defining a server storage group, a load balancer route the request to a first server that processes request and any related session information, storing any altered first session data in a data storage. The load balancer receives a second request, wherein the second request also has the same storage group mark. The load balance selects a second server to respond to the second request As before, the second server processes the second request and the altered first session data loaded from the data storage. After processing, the second server stores any altered second session data in the stored data on the first server as well as the second server and returns the altered second session data.
    • 提供通过公共通信网络访问数据的方法包括接收具有存储组标记的第一数据会话请求,定义服务器存储组的存储组标记,负载平衡器将请求路由到处理请求的第一服务器, 任何相关会话信息,将任何改变的第一会话数据存储在数据存储器中。 负载平衡器接收第二请求,其中第二请求也具有相同的存储组标记。 负载平衡选择第二服务器来响应第二请求如前所述,第二服务器处理从数据存储器加载的第二请求和改变的第一会话数据。 在处理之后,第二服务器将存储的数据中的任何改变的第二会话数据存储在第一服务器以及第二服务器上,并返回改变的第二会话数据。